Skip to main content

Table 1 The characteristics of patients enrolled in this study

From: Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy

Disease site

Case number

%

Prescription

Pelvis

135

67.16

45 Gy/25fx

 Gynecologic cancer

83

41.29

 

 Rectal cancer

44

21.89

 

 Prostate cancer

8

3.98

 

Head and Neck

66

32.84

60 Gy/30fx

 Nasopharyngeal cancer

34

16.95

 

 Laryngeal cancer

19

9.45

 

 Hypopharyngeal cancer

13

6.47

Â